Replies to post #27779 on Curative Biotechnology Inc (CUBT)

[Mooseface]

The licensed patent rights include US Patent No. 10,548,987 issued February 02, 2020 (Patent Application No. 15/747,620 filed January 25, 2018). HHS Ref. No. E-221-2015-0-US-03. “ANTIBODY – DRUG CONJUGATES FOR TARGETING CD56 – POSITIVE TUMORS.” The territory is worldwide.

Yes, there's a patent.